cefazolin
Generic: cefazolin
Labeler: wg critical care, llcDrug Facts
Product Profile
Brand Name
cefazolin
Generic Name
cefazolin
Labeler
wg critical care, llc
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Routes
Active Ingredients
cefazolin sodium 3 g/1
Manufacturer
Identifiers & Regulatory
Product NDC
44567-845
Product ID
44567-845_f295b581-42f2-4a83-bd35-58d21fa32dda
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA211413
Listing Expiration
2026-12-31
Marketing Start
2024-05-10
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
44567845
Hyphenated Format
44567-845
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cefazolin (source: ndc)
Generic Name
cefazolin (source: ndc)
Application Number
NDA211413 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 3 g/1
Packaging
- 25 VIAL in 1 CARTON (44567-845-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (44567-845-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "f295b581-42f2-4a83-bd35-58d21fa32dda", "openfda": {"unii": ["P380M0454Z"], "rxcui": ["1665060", "2630753"], "spl_set_id": ["4f3a9248-a354-4c77-bf5b-9eed38f00219"], "manufacturer_name": ["WG Critical Care, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (44567-845-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (44567-845-01)", "package_ndc": "44567-845-25", "marketing_start_date": "20240510"}], "brand_name": "Cefazolin", "product_id": "44567-845_f295b581-42f2-4a83-bd35-58d21fa32dda", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "44567-845", "generic_name": "Cefazolin", "labeler_name": "WG Critical Care, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cefazolin", "active_ingredients": [{"name": "CEFAZOLIN SODIUM", "strength": "3 g/1"}], "application_number": "NDA211413", "marketing_category": "NDA", "marketing_start_date": "20240510", "listing_expiration_date": "20261231"}